Published in Hum Mol Genet on December 01, 1997
A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p. Am J Hum Genet (2001) 3.54
A genomewide screen of 345 families for autism-susceptibility loci. Am J Hum Genet (2003) 2.51
Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. Am J Hum Genet (2005) 2.44
Autism: the phenotype in relatives. J Autism Dev Disord (1998) 2.37
Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers. Am J Hum Genet (1998) 1.87
Genetic-linkage mapping of complex hereditary disorders to a whole-genome molecular-interaction network. Genome Res (2008) 1.71
The 5-HT transporter gene-linked polymorphic region (5-HTTLPR) in evolutionary perspective: alternative biallelic variation in rhesus monkeys. Rapid communication. J Neural Transm (Vienna) (1997) 1.65
Etiology of infantile autism: a review of recent advances in genetic and neurobiological research. J Psychiatry Neurosci (1999) 1.54
Gene-environment interaction and the genetics of depression. J Psychiatry Neurosci (2004) 1.46
Genetic studies of autism: from the 1970s into the millennium. J Abnorm Child Psychol (2000) 1.27
Sex-specific genetic architecture of whole blood serotonin levels. Am J Hum Genet (2004) 1.26
Current developments in the genetics of autism: from phenome to genome. J Neuropathol Exp Neurol (2008) 1.26
Autism, Alzheimer disease, and fragile X: APP, FMRP, and mGluR5 are molecular links. Neurology (2011) 1.20
Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder. Mol Psychiatry (2002) 1.15
Heterogeneity and the genetics of autism. J Psychiatry Neurosci (1999) 1.12
Antipsychotics in the treatment of autism. J Clin Invest (2008) 1.06
Autism spectrum and obsessive-compulsive disorders: OC behaviors, phenotypes and genetics. Autism Res (2009) 0.96
Early pharmacological treatment of autism: a rationale for developmental treatment. Biol Psychiatry (2007) 0.95
Association and gene-gene interaction of SLC6A4 and ITGB3 in autism. Am J Med Genet B Neuropsychiatr Genet (2010) 0.94
Hyperserotoninemia and altered immunity in autism. J Autism Dev Disord (2006) 0.90
MAOA, DBH, and SLC6A4 variants in CHARGE: a case-control study of autism spectrum disorders. Autism Res (2011) 0.89
Parent-of-origin effects of the serotonin transporter gene associated with autism. Am J Med Genet B Neuropsychiatr Genet (2010) 0.86
Allele-specific associations of 5-HTTLPR/rs25531 with ADHD and autism spectrum disorder. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.86
Common variants in genes of the postsynaptic FMRP signalling pathway are risk factors for autism spectrum disorders. Hum Genet (2014) 0.85
Lack of association of the serotonin transporter polymorphism with the sudden infant death syndrome in the San Diego Dataset. Pediatr Res (2010) 0.83
Serotonin transporter gene polymorphism and psychiatric disorders: is there a link? Indian J Psychiatry (2011) 0.83
The influence of serotonin transporter polymorphisms on cortical activity: a resting EEG study. BMC Neurosci (2011) 0.81
Valproic acid silencing of ascl1b/Ascl1 results in the failure of serotonergic differentiation in a zebrafish model of fetal valproate syndrome. Dis Model Mech (2013) 0.81
The 5-HTTLPR polymorphism in South African healthy populations: a global comparison. J Neural Transm (Vienna) (2008) 0.80
Investigation of two variants in the DOPA decarboxylase gene in patients with autism. Am J Med Genet (2002) 0.78
A review of the serotonin transporter and prenatal cortisol in the development of autism spectrum disorders. Mol Autism (2013) 0.78
Emerging drugs for the treatment of symptoms associated with autism spectrum disorders. Expert Opin Emerg Drugs (2010) 0.77
Common EIF4E variants modulate risk for autism spectrum disorders in the high-functioning range. J Neural Transm (Vienna) (2014) 0.76
Association between the STin2 VNTR polymorphism and smoking behavior in oral cancer patients and healthy individuals. Clin Exp Med (2011) 0.76
The genetic overlap of attention deficit hyperactivity disorder and autistic spectrum disorder. Appl Clin Genet (2009) 0.76
Lambda replacement vectors carrying polylinker sequences. J Mol Biol (1983) 32.76
Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med (2000) 16.30
A physical map of the human genome. Nature (2001) 12.39
Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer (1997) 8.27
Allelic variation of human serotonin transporter gene expression. J Neurochem (1996) 7.08
X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet (1998) 6.82
Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature (1990) 5.13
Systematic subcellular localization of novel proteins identified by large-scale cDNA sequencing. EMBO Rep (2000) 5.06
Imprint switching on human chromosome 15 may involve alternative transcripts of the SNRPN gene. Nat Genet (1996) 4.36
Cloning of the T gene required in mesoderm formation in the mouse. Nature (1990) 4.20
p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood (1995) 4.12
Selective isolation of cosmid clones by homologous recombination in Escherichia coli. Proc Natl Acad Sci U S A (1984) 4.11
Toward a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs. Genome Res (2001) 3.97
A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat Genet (1996) 3.67
Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature (2000) 3.61
Pharmacogenetic prediction of clozapine response. Lancet (2000) 3.10
Analysis of cosmids using linearization by phage lambda terminase. Gene (1985) 2.98
Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. Mol Pharmacol (1998) 2.94
Early experience and serotonin transporter gene variation interact to influence primate CNS function. Mol Psychiatry (2002) 2.85
Serotonin transporter gene polymorphism, differential early rearing, and behavior in rhesus monkey neonates. Mol Psychiatry (2002) 2.65
A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry (1996) 2.60
Construction and use of human chromosome jumping libraries from NotI-digested DNA. Nature (1987) 2.58
Sequence interpretation. Functional annotation of mouse genome sequences. Science (2001) 2.54
Dickkopf genes are co-ordinately expressed in mesodermal lineages. Mech Dev (1999) 2.36
Primer design for large scale sequencing. Nucleic Acids Res (1998) 2.31
A missense mutation in a novel gene encoding a putative cation channel is associated with catatonic schizophrenia in a large pedigree. Mol Psychiatry (2001) 2.27
Active and inactive genes localize preferentially in the periphery of chromosome territories. J Cell Biol (1996) 2.25
Clustering of multiallele DNA markers near the Huntington's disease gene. J Clin Invest (1989) 2.25
Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array. Genome Res (2001) 2.25
Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proc Natl Acad Sci U S A (1998) 2.22
Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc Natl Acad Sci U S A (2001) 2.19
DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours. Nat Genet (1997) 2.18
Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia. Leukemia (2004) 2.08
No effect of acute tryptophan depletion on verbal declarative memory in young persons with ADHD. Acta Psychiatr Scand (2013) 2.07
Exclusion of the neuronal nicotinic acetylcholine receptor alpha7 subunit gene as a candidate for catatonic schizophrenia in a large family supporting the chromosome 15q13-22 locus. Mol Psychiatry (2002) 2.01
Molecular approaches to mammalian genetics. Cold Spring Harb Symp Quant Biol (1986) 1.99
Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet (1999) 1.98
Genotype-phenotype relationship in female carriers of the premutation and full mutation of FMR-1. Psychiatry Res (1998) 1.95
Fragile X syndrome without CCG amplification has an FMR1 deletion. Nat Genet (1992) 1.91
The utility of the non-human primate; model for studying gene by environment interactions in behavioral research. Genes Brain Behav (2003) 1.91
Processing and quality control of DNA array hybridization data. Bioinformatics (2000) 1.86
Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1. Br J Haematol (1999) 1.84
X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene. Am J Hum Genet (1999) 1.80
Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. J Clin Invest (2000) 1.80
Overlap of dyskeratosis congenita with the Hoyeraal-Hreidarsson syndrome. J Pediatr (2000) 1.74
A microdeletion of less than 250 kb, including the proximal part of the FMR-I gene and the fragile-X site, in a male with the clinical phenotype of fragile-X syndrome. Am J Hum Genet (1992) 1.73
High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia. Leukemia (2005) 1.72
A complex pattern of evolutionary conservation and alternative polyadenylation within the long 3"-untranslated region of the methyl-CpG-binding protein 2 gene (MeCP2) suggests a regulatory role in gene expression. Hum Mol Genet (1999) 1.70
Cloning of gp-340, a putative opsonin receptor for lung surfactant protein D. Proc Natl Acad Sci U S A (1999) 1.69
Role of serotonin in the immune system and in neuroimmune interactions. Brain Behav Immun (1998) 1.69
11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood (1997) 1.69
Response to thalidomide in progressive multiple myeloma is not mediated by inhibition of angiogenic cytokine secretion. Br J Haematol (2001) 1.68
Dissemination of tumor cells in patients undergoing surgery for colorectal cancer. Clin Cancer Res (1998) 1.68
Identifying splits with clear separation: a new class discovery method for gene expression data. Bioinformatics (2001) 1.67
The 5-HT transporter gene-linked polymorphic region (5-HTTLPR) in evolutionary perspective: alternative biallelic variation in rhesus monkeys. Rapid communication. J Neural Transm (Vienna) (1997) 1.65
MASA syndrome is due to mutations in the neural cell adhesion gene L1CAM. Nat Genet (1994) 1.62
Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup. J Clin Oncol (2004) 1.62
[Reliability and factorial validity of the Child Behavior Checklist--an analysis of a clinical and field sample]. Z Kinder Jugendpsychiatr (1994) 1.61
Laparoscopic restorative proctocolectomy. Br J Surg (2005) 1.60
Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases. Br J Cancer (2005) 1.59
Stability and interpersonal agreement of the interview-based diagnosis of autism. Psychopathology (2001) 1.57
Exploring the genetic link between RLS and ADHD. J Psychiatr Res (2009) 1.55
High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma. Clin Cancer Res (2001) 1.51
High expression of APO-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children. Blood (1994) 1.50
S100-Beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma. J Clin Oncol (1999) 1.49
Screening of nine candidate genes for autism on chromosome 2q reveals rare nonsynonymous variants in the cAMP-GEFII gene. Mol Psychiatry (2003) 1.47
Reduction in the density and expression, but not G-protein coupling, of serotonin receptors (5-HT1A) in 5-HT transporter knock-out mice: gender and brain region differences. J Neurosci (2000) 1.46
Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children. Blood (1996) 1.46
A yeast artificial chromosome telomere clone spanning a possible location of the Huntington disease gene. Am J Hum Genet (1990) 1.41
A 16-year-old boy with severe gamma-butyrolactone (GBL) withdrawal delirium. Pharmacopsychiatry (2009) 1.40
The human serotonin transporter gene polymorphism--basic research and clinical implications. J Neural Transm (Vienna) (1997) 1.39
Physical maps of 4p16.3, the area expected to contain the Huntington disease mutation. Genomics (1990) 1.39
Functional imbalance of visual pathways indicates alternative face processing strategies in autism. Neurology (2003) 1.35
Barrel pattern formation requires serotonin uptake by thalamocortical afferents, and not vesicular monoamine release. J Neurosci (2001) 1.34
Excessive activation of serotonin (5-HT) 1B receptors disrupts the formation of sensory maps in monoamine oxidase a and 5-ht transporter knock-out mice. J Neurosci (2001) 1.33
DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer. Cancer Res (2000) 1.32
Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter. Eur J Neurosci (2000) 1.29
A strategy for the selection of transcribed sequences in the Xq28 region. Hum Mol Genet (1992) 1.28
The (6;9) chromosome translocation, associated with a specific subtype of acute nonlymphocytic leukemia, leads to aberrant transcription of a target gene on 9q34. Mol Cell Biol (1990) 1.27
Long-term outcome of nonmyeloablative allogeneic transplantation in patients with high-risk multiple myeloma. Bone Marrow Transplant (2005) 1.27
Human histone gene organization: nonregular arrangement within a large cluster. Genomics (1997) 1.27
Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions. Neuroscience (2002) 1.26
Construction of a NotI linking library and isolation of new markers close to the Huntington's disease gene. Nucleic Acids Res (1988) 1.24
Functional promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene. J Neural Transm Gen Sect (1995) 1.23
Mutations in the ribosomal protein gene RPL10 suggest a novel modulating disease mechanism for autism. Mol Psychiatry (2006) 1.23
Down-regulation of insulin-like growth factor-I receptor and insulin receptor substrate-1 expression in advanced human breast cancer. Int J Cancer (2000) 1.22
High density of FOXP3-positive T cells infiltrating colorectal cancers with microsatellite instability. Br J Cancer (2008) 1.20
Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice. J Pharmacol Exp Ther (1999) 1.20
On the prognostic value of survival models with application to gene expression signatures. Stat Med (2010) 1.20
Genomic organization of the adrenoleukodystrophy gene. Genomics (1994) 1.19
Amygdala responsiveness is modulated by tryptophan hydroxylase-2 gene variation. J Neural Transm (Vienna) (2005) 1.19
Detection of hematogenic tumor cell dissemination in patients undergoing resection of liver metastases of colorectal cancer. Ann Surg (2000) 1.18
Dyskerin localizes to the nucleolus and its mislocalization is unlikely to play a role in the pathogenesis of dyskeratosis congenita. Hum Mol Genet (1999) 1.18
Genome-wide linkage analysis of ADHD using high-density SNP arrays: novel loci at 5q13.1 and 14q12. Mol Psychiatry (2008) 1.18
Splitting schizophrenia: periodic catatonia-susceptibility locus on chromosome 15q15. Am J Hum Genet (2000) 1.17
A family of cosmid vectors with the multi-copy R6K replication origin. Gene (1987) 1.16
Alternative splicing in the fragile X gene FMR1. Hum Mol Genet (1993) 1.16
The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28. Genomics (1995) 1.16